Alessandro Vatrella

ResearcherID Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 29

Top Venues

Journal of clinical medicine

International journal of molecular sciences

Biomedicines

Journal of asthma and allergy

Università degli Studi di Salerno Dipartimento di Medicina e Chirurgia

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Università degli Studi di Salerno Dipartimento di Medicina e Chirurgia Nov 01 2006

Italy

Associate Professor

Publications

Corrado Pelaia, Antonio Giacalone, Gianluca Ippolito, Daniela Pastore, Angelantonio Maglio, Giovanna Lucia Piazzetta, Nadia Lobello, Nicola Lombardo, Alessandro Vatrella, Girolamo Pelaia
Difficult-To-Treat and Severe Asthma: Can Real-World Studies On Effectiveness of Biological Treatments Change the Lives of Patients? Pragmatic and observational research 15 (2024)
Corrado Pelaia, Antonio Giacalone, Gianluca Ippolito, Daniela Pastore, Angelantonio Maglio, Giovanna Lucia Piazzetta, Nadia Lobello, Nicola Lombardo, Alessandro Vatrella, Girolamo Pelaia
Difficult-To-Treat and Severe Asthma: Can Real-World Studies On Effectiveness of Biological Treatments Change the Lives of Patients? Pragmatic and observational research 15 (2024)
Carolina Vitale, Angelantonio Maglio, Corrado Pelaia, Maria D'Amato, Luigi Ciampo, Giulia Pelaia, Antonio Molino, Alessandro Vatrella
Effectiveness of Benralizumab in OCS-Dependent Severe Asthma: The Impact of 2 Years of Therapy in a Real-Life Setting. Journal of clinical medicine 12 (3) (2023)
Angelantonio Maglio, Carolina Vitale, Corrado Pelaia, Maria D'Amato, Luigi Ciampo, Eliana Sferra, Antonio Molino, Giulia Pelaia, Alessandro Vatrella
Severe Asthma Remissions Induced by Biologics Targeting IL5/IL5r: Results from a Multicenter Real-Life Study. International journal of molecular sciences 24 (3) (2023)
Carolina Vitale, Angelantonio Maglio, Corrado Pelaia, Maria D'Amato, Luigi Ciampo, Giulia Pelaia, Antonio Molino, Alessandro Vatrella
Effectiveness of Benralizumab in OCS-Dependent Severe Asthma: The Impact of 2 Years of Therapy in a Real-Life Setting. Journal of clinical medicine 12 (3) (2023)
Angelantonio Maglio, Carolina Vitale, Corrado Pelaia, Maria D'Amato, Luigi Ciampo, Eliana Sferra, Antonio Molino, Giulia Pelaia, Alessandro Vatrella
Severe Asthma Remissions Induced by Biologics Targeting IL5/IL5r: Results from a Multicenter Real-Life Study. International journal of molecular sciences 24 (3) (2023)
Giulia Scioscia, Pasquale Tondo, Santi Nolasco, Corrado Pelaia, Giovanna Elisiana Carpagnano, Maria Filomena Caiaffa, Giuseppe Valenti, Angelantonio Maglio, Francesco Papia, Massimo Triggiani, Nunzio Crimi, Girolamo Pelaia, Alessandro Vatrella, Maria Pia Foschino Barbaro, Claudia Crimi
Benralizumab in Patients with Severe Eosinophilic Asthma: A Multicentre Real-Life Experience. Journal of clinical medicine 12 (13) (2023)
Carolina Vitale, Angelantonio Maglio, Corrado Pelaia, Maria D'Amato, Luigi Ciampo, Giulia Pelaia, Antonio Molino, Alessandro Vatrella
Effectiveness of Benralizumab in OCS-Dependent Severe Asthma: The Impact of 2 Years of Therapy in a Real-Life Setting. Journal of clinical medicine 12 (3) (2023)
Angelantonio Maglio, Carolina Vitale, Corrado Pelaia, Maria D'Amato, Luigi Ciampo, Eliana Sferra, Antonio Molino, Giulia Pelaia, Alessandro Vatrella
Severe Asthma Remissions Induced by Biologics Targeting IL5/IL5r: Results from a Multicenter Real-Life Study. International journal of molecular sciences 24 (3) (2023)
Angelantonio Maglio, Carolina Vitale, Corrado Pelaia, Maria D'Amato, Luigi Ciampo, Eliana Sferra, Antonio Molino, Giulia Pelaia, Alessandro Vatrella
Severe Asthma Remissions Induced by Biologics Targeting IL5/IL5r: Results from a Multicenter Real-Life Study. International journal of molecular sciences 24 (3) (2023)
Corrado Pelaia, Giuseppe Armentaro, Chiara Lupia, Antonio Maiorano, Nicola Montenegro, Sofia Miceli, Valentino Condoleo, Velia Cassano, Andrea Bruni, Eugenio Garofalo, Claudia Crimi, Alessandro Vatrella, Girolamo Pelaia, Federico Longhini, Angela Sciacqua
Effects of High-Flow Nasal Cannula on Right Heart Dysfunction in Patients with Acute-on-Chronic Respiratory Failure and Pulmonary Hypertension. Journal of clinical medicine 12 (17) (2023)
Corrado Pelaia, Anna Ferrante Bannera, Fioramante Lello Rotundo, Francesco Giuseppe Tropea, Giuseppe Armentaro, Angelantonio Maglio, Angela Sciacqua, Alessandro Vatrella, Girolamo Pelaia
Clinical and Functional Effects of Inhaled Dual Therapy Umeclidinium/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease: A Real-Life Study. International journal of chronic obstructive pulmonary disease 18 (2023)
Raffaele Campisi, Santi Nolasco, Corrado Pelaia, Pietro Impellizzeri, Maria D'Amato, Andrea Portacci, Luisa Ricciardi, Giulia Scioscia, Nunzio Crimi, Nicola Scichilone, Maria Pia Foschino Barbaro, Girolamo Pelaia, Giovanna Elisiana Carpagnano, Alessandro Vatrella, Claudia Crimi, null null
Benralizumab Effectiveness in Severe Eosinophilic Asthma with Co-Presence of Bronchiectasis: A Real-World Multicentre Observational Study. Journal of clinical medicine 12 (12) (2023)
Raffaele Campisi, Santi Nolasco, Corrado Pelaia, Pietro Impellizzeri, Maria D'Amato, Andrea Portacci, Luisa Ricciardi, Giulia Scioscia, Nunzio Crimi, Nicola Scichilone, Maria Pia Foschino Barbaro, Girolamo Pelaia, Giovanna Elisiana Carpagnano, Alessandro Vatrella, Claudia Crimi, null null
Benralizumab Effectiveness in Severe Eosinophilic Asthma with Co-Presence of Bronchiectasis: A Real-World Multicentre Observational Study. Journal of clinical medicine 12 (12) (2023)
Corrado Pelaia, Giulia Pelaia, Angelantonio Maglio, Caterina Tinello, Lucia Muraca, Nicola Lombardo, Rosa Terracciano, Alessandro Vatrella
Pathobiology of Type 2 Inflammation in Asthma and Nasal Polyposis. Journal of clinical medicine 12 (10) (2023)
Corrado Pelaia, Giulia Pelaia, Claudia Crimi, Angelantonio Maglio, Giuseppe Armentaro, Cecilia Calabrese, Angela Sciacqua, Lucia Muraca, Alessandro Vatrella
Biological Therapy of Severe Asthma with Dupilumab, a Dual Receptor Antagonist of Interleukins 4 and 13. Vaccines 10 (6) (2022)
Alessandro Vatrella, Angelantonio Maglio, Corrado Pelaia, Luigi Ciampo, Giulia Pelaia, Carolina Vitale
Eosinophilic inflammation: An Appealing Target for Pharmacologic Treatments in Severe Asthma. Biomedicines 10 (9) (2022)
Corrado Pelaia, Giulia Pelaia, Claudia Crimi, Angelantonio Maglio, Anna Agnese Stanziola, Cecilia Calabrese, Rosa Terracciano, Federico Longhini, Alessandro Vatrella
Novel Biological Therapies for Severe Asthma Endotypes. Biomedicines 10 (5) (2022)
Valeria Visco, Carolina Vitale, Antonella Rispoli, Carmine Izzo, Nicola Virtuoso, Germano Junior Ferruzzi, Mario Santopietro, Americo Melfi, Maria Rosaria Rusciano, Angelantonio Maglio, Paola Di Pietro, Albino Carrizzo, Gennaro Galasso, Alessandro Vatrella, Carmine Vecchione, Michele Ciccarelli
Post-COVID-19 Syndrome: Involvement and Interactions between Respiratory, Cardiovascular and Nervous Systems. Journal of clinical medicine 11 (3) (2022)
Corrado Pelaia, Giulia Pelaia, Claudia Crimi, Angelantonio Maglio, Lucia Muraca, Rosa Terracciano, Alessandro Vatrella
Tezepelumab: A Potential New Biological Therapy for Severe Refractory Asthma. International journal of molecular sciences 22 (9) (2021)
Corrado Pelaia, Giulia Pelaia, Federico Longhini, Claudia Crimi, Cecilia Calabrese, Lucia Muraca, Angela Sciacqua, Alessandro Vatrella
Monoclonal Antibodies Targeting Alarmins: A New Perspective for Biological Therapies of Severe Asthma. Biomedicines 9 (9) (2021)
Corrado Pelaia, Claudia Crimi, Alida Benfante, Maria Filomena Caiaffa, Cecilia Calabrese, Giovanna Elisiana Carpagnano, Domenico Ciotta, Maria D'Amato, Luigi Macchia, Santi Nolasco, Girolamo Pelaia, Simona Pellegrino, Nicola Scichilone, Giulia Scioscia, Giuseppe Spadaro, Giuseppe Valenti, Alessandro Vatrella, Nunzio Crimi
Therapeutic Effects of Benralizumab Assessed in Patients with Severe Eosinophilic Asthma: Real-Life Evaluation Correlated with Allergic and Non-Allergic Phenotype Expression. Journal of asthma and allergy 14 (2021)
Corrado Pelaia, Nicola Lombardo, Maria Teresa Busceti, Giovanna Piazzetta, Claudia Crimi, Cecilia Calabrese, Alessandro Vatrella, Girolamo Pelaia
Short-Term Evaluation of Dupilumab Effects in Patients with Severe Asthma and Nasal Polyposis. Journal of asthma and allergy 14 (2021)
Angelantonio Maglio, Carolina Vitale, Simona Pellegrino, Cecilia Calabrese, Maria D'Amato, Antonio Molino, Corrado Pelaia, Massimo Triggiani, Girolamo Pelaia, Cristiana Stellato, Alessandro Vatrella
Real-Life Effectiveness of Mepolizumab on Forced Expiratory Flow between 25% and 75% of Forced Vital Capacity in Patients with Severe Eosinophilic Asthma. Biomedicines 9 (11) (2021)
Corrado Pelaia, Alessandro Vatrella, Lucia Muraca, Nicola Lombardo, Angela Sciacqua, Rocco Savino, Girolamo Pelaia
Role of p38 Mitogen-Activated Protein Kinase in Asthma and COPD: Pathogenic Aspects and Potential Targeted Therapies. Drug design, development and therapy 15 (2021)
Chiara Colarusso, Angelantonio Maglio, Michela Terlizzi, Carolina Vitale, Antonio Molino, Aldo Pinto, Alessandro Vatrella, Rosalinda Sorrentino
Post-COVID-19 Patients Who Develop Lung Fibrotic-like Changes Have Lower Circulating Levels of IFN-β but Higher Levels of IL-1α and TGF-β. Biomedicines 9 (12) (2021)
Corrado Pelaia, Cecilia Calabrese, Eugenio Garofalo, Andrea Bruni, Alessandro Vatrella, Girolamo Pelaia
Therapeutic Role of Tocilizumab in SARS-CoV-2-Induced Cytokine Storm: Rationale and Current Evidence. International journal of molecular sciences 22 (6) (2021)
Valeria Conti, Graziamaria Corbi, Valentina Manzo, Paola Malangone, Carolina Vitale, Angelantonio Maglio, Roberta Cotugno, Damiano Capaccio, Luigi Marino, Carmine Selleri, Cristiana Stellato, Filippelli Amelia, Alessandro Vatrella
SIRT1 Activity in Peripheral Blood Mononuclear Cells Correlates with Altered Lung Function in Patients with Chronic Obstructive Pulmonary Disease. Oxidative medicine and cellular longevity 2018 (2018)
Corrado Pelaia, Cecilia Calabrese, Alessandro Vatrella, Maria Teresa Busceti, Eugenio Garofalo, Nicola Lombardo, Rosa Terracciano, Girolamo Pelaia
Benralizumab: From the Basic Mechanism of Action to the Potential Use in the Biological Therapy of Severe Eosinophilic Asthma. BioMed research international 2018 (2018)

Alessandro Vatrella.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Alessandro Vatrella